BioMonitor 2 in-office setting insertion safety and feasibility evaluation with device functionality assessment: results from the prospective cohort BioInsight study.

Background: Insertable cardiac monitors are utilized for the diagnosis of arrhythmias and traditionally have been inserted within hospitals. Recent code updates allow for reimbursement of office-based insertions; however, there is limited information regarding the resources and processes required to support in-office insertions. We sought to determine the safety and feasibility of in-office insertion of the BioMonitor 2 and better understand in-office procedures, including patient selection, pre-insertion protocols, resource availability, and staff support.

Atrial Fibrillation in the Elderly.

Atrial fibrillation is a common cardiac arrhythmia affecting up to 5% of people over the age of 65 years. The elderly are less well able to withstand the hemodynamic stress of new-onset and rapid atrial fibrillation. Advancing age is a predisposing factor for atrial fibrillation itself and for its complications.